Matches in DBpedia 2016-04 for { <http://www.nelm.nhs.uk/en/NeLM-Area/News/2009---October/29/Canakinumab-Ilaris-and-rilonacept-Arcalyst-approved-in-EU-for-treatment-of-cryopyrin-associated-periodic-syndrome/> ?p ?o }
Showing triples 1 to 8 of
8
with 100 triples per page.
- Canakinumab-Ilaris-and-rilonacept-Arcalyst-approved-in-EU-for-treatment-of-cryopyrin-associated-periodic-syndrome accessdate "2010-04-14".
- Canakinumab-Ilaris-and-rilonacept-Arcalyst-approved-in-EU-for-treatment-of-cryopyrin-associated-periodic-syndrome date "2009-10-29".
- Canakinumab-Ilaris-and-rilonacept-Arcalyst-approved-in-EU-for-treatment-of-cryopyrin-associated-periodic-syndrome first "Yuet".
- Canakinumab-Ilaris-and-rilonacept-Arcalyst-approved-in-EU-for-treatment-of-cryopyrin-associated-periodic-syndrome isCitedBy Canakinumab.
- Canakinumab-Ilaris-and-rilonacept-Arcalyst-approved-in-EU-for-treatment-of-cryopyrin-associated-periodic-syndrome last "Wan".
- Canakinumab-Ilaris-and-rilonacept-Arcalyst-approved-in-EU-for-treatment-of-cryopyrin-associated-periodic-syndrome publisher "National electronic Library for Medicines".
- Canakinumab-Ilaris-and-rilonacept-Arcalyst-approved-in-EU-for-treatment-of-cryopyrin-associated-periodic-syndrome title "Canakinumab and rilonacept approved in EU for treatment of cryopyrin-associated periodic syndrome".
- Canakinumab-Ilaris-and-rilonacept-Arcalyst-approved-in-EU-for-treatment-of-cryopyrin-associated-periodic-syndrome url Canakinumab-Ilaris-and-rilonacept-Arcalyst-approved-in-EU-for-treatment-of-cryopyrin-associated-periodic-syndrome.